BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AWT020 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AWT020\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06839105-2370@assetmemo.bio
DTSTAMP:20261121T005448Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:AWT020: Phase 1 readout est. (NCT06839105)
DESCRIPTION:AWT020\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Clinic
 al Study to Evaluate the Safety and Tolerability of AWT020 in Patients Wit
 h Advanced Malignancies\nEstimated primary completion: 30 April 2028. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/awt020#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT06839105
URL:https://assetmemo.bio/drug/awt020#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07822919-2370@assetmemo.bio
DTSTAMP:20261121T005448Z
DTSTART;VALUE=DATE:20290131
DTEND;VALUE=DATE:20290201
SUMMARY:AWT020: Phase 1 readout est. (NCT07822919)
DESCRIPTION:AWT020\, phase 1.\nStudy: A Study of AWT020 in Participants Wit
 h Advanced Solid Tumors\nEstimated primary completion: January 2029. This 
 is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it c
 an move.\nDrug page: https://assetmemo.bio/drug/awt020#upcoming-events\nRe
 gistry record: https://clinicaltrials.gov/study/NCT07822919
URL:https://assetmemo.bio/drug/awt020#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
